( d ) Assay was run in technical quadruplicate (mGIPR-Ab) and triplicate (GIP)
We built two baskets of leading drugmakers: one focused on GLP-1 producers (Novo Nordisk, Eli Lilly, Sanofi, Teva and Hikma), and another on non-GLP-1 peers (Novartis, Johnson & Johnson, GlaxoSmithKline, AbbVie and Bayer)
Critical reviews include complaints about medication that produced no appetite suppression or weight loss and communication delays
Competitive intelligence reveals that companies are focusing on future development strategies, such as novel formulations and broader indications, to strengthen their positioning
The human body actively resists extreme caloric restriction by slowing the basal metabolic rate and increasing ghrelin production, making long-term adherence nearly impossible for the average patient